Related Experiment Video

Updated: May 15, 2026

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
11:27

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α

Published on: November 2, 2018

Kinase-independent feedback of the TAK1/TAB1 complex on BCL10 turnover and NF-κB activation

Miguel E Moreno-García1, Karen Sommer, Hector Rincon-Arano

  • 1Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, Washington, USA.

Molecular and Cellular Biology
|January 9, 2013
PubMed

Insights

TAK1 and TAB1 are crucial for antigen receptor-induced BCL10 degradation, limiting lymphocyte survival signals. TAK1 targets BCL10 for degradation, counteracting NF-κB and JNK pathways in lymphoma.

Area of Science:

  • Immunology
  • Cell Biology
  • Oncology

Background:

  • Antigen receptors control lymphocyte survival, proliferation, and differentiation via pathways like NF-κB and JNK.
  • CARMA1 scaffolding protein activates these pathways, and its mutations drive diffuse large B cell lymphoma (DLBCL).
  • BCL10 activation and subsequent degradation limit signaling downstream of CARMA1.

Purpose of the Study:

  • To investigate the role of TAK1 and TAB1 in antigen receptor-induced BCL10 degradation.
  • To elucidate the mechanism by which TAK1 regulates BCL10 levels.
  • To determine TAK1's functional impact on NF-κB and JNK signaling in lymphocytes and DLBCL.

Main Methods:

  • Utilized lymphocyte cell models to study antigen receptor signaling.
  • Investigated the kinase-independent role of TAK1 and TAB1 in BCL10 degradation.
  • Examined TAK1's function as an adaptor for E3 ubiquitin ligases targeting BCL10.
  • Assessed the effects of TAK1 overexpression on NF-κB and JNK activation.

Main Results:

  • Identified a kinase-independent requirement for TAK1 and TAB1 in antigen receptor-induced BCL10 degradation.
  • Demonstrated that TAK1 acts as an adaptor for E3 ubiquitin ligases that degrade BCL10.
  • Showed that TAK1 overexpression restrains CARMA1-dependent NF-κB activation by reducing BCL10 levels.
  • Revealed that TAK1 promotes counterselection of NF-κB-addicted DLBCL lines via BCL10 degradation and JNK activation.

Conclusions:

  • TAK1 directly promotes BCL10 degradation, acting as a critical regulator of antigen receptor signaling.
  • TAK1 counterbalances NF-κB and JNK signals essential for lymphocyte activation and survival.
  • TAK1's dual mechanism of action offers therapeutic potential against CARMA1-addicted lymphomas.

More Related Videos

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells10:57

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells

Published on: January 12, 2020

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...